PSYCHIATRIC MEDICATIONS FOR CHILDREN FOCUS OF TWO PRESENTATIONS AT UNK TUESDAY BY NATIONAL AUTHORITY

Dr. Jeanne Stolzer
Department of Family Studies and Interior Design, 308.865.8234

Dr. David Cohen, professor of social welfare at Florida International University in Miami, will examine the issue of medicating children from historical, cultural, ethical and scientific perspectives in two presentations on the University of Nebraska at Kearney campus Tuesday, April 27.

At 1 p.m. in the Miriam Drake Theatre, he will present Conflicts of Interest in Clinical Trials of Psychiatric Drugs.

At 7 p.m., in the Great Room of the Nebraskan Student Union, he will presentCritiques of the ADHD Enterprise. Both presentations are free and open to the public.

Using the example of a recently-approved drug for the treatment of “adult ADD,” Dr. Cohen will talk about how conflicts of interest are shaping the way that clinical drug trials are conducted. According to Dr. Cohen, conflicts of interest are adversely shaping clinical drug trials, leading to vital information being concealed from consumers and health care providers.

Dr. Cohen is co-author of Your Drug May Be Your Problem: How and Why to Stop Taking Psychiatric Medications.

The book is touted as being the first popular book to emphasize the risks of psychiatric drug withdrawal and offer practical steps for safe discontinuation.

He has authored numerous articles on psychiatric medications in journals in sociology, psychology, medicine, law, policy and social work, and editedEthical Human Sciences and Services. He has lectured throughout the world. Last year, he received the Elliot Freidson Award from the American Sociological Association for outstanding publication in medical sociology.